Search Results 351-360 of 8847 for Conduction

1. A Study of the Effect of Ezogabine on Motor Neuron Excitability in Patients with Amyotrophic Lateral Sclerosis - Mayo Clinic

   Clinically significant conduction abnormalities on electrocardiogram or a known history of cardiac arrhythmia, myocardial infarction within the past 24 ...

2. A Study to Evaluate AAV8-human Cocaine Hydrolase to Treat Cocaine Use Disorder - Mayo Clinic

   Show a baseline EKG that demonstrates normal sinus rhythm and conduction without clinically significant abnormalities or arrhythmias. Are willing to return ...

3. A Study to Evaluate the Efficacy and Safety of GSK3915393 in Participants With Idiopathic Pulmonary Fibrosis (IPF) - Mayo Clinic

   * Clinically significant abnormalities detected on ECG of either rhythm or conduction, a Corrected QT interval (QTc) >450 millisecond (msec) or QTc ...

4. Buparlisib in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma - Mayo Clinic

   Conduction abnormality requiring a pacemaker; Symptomatic pericarditis; Myocardial infraction within the last 6 months, documented by persistent elevated ...

5. UT Split Tear Overview-Wrist pain - Youtube

   There is a nerve that goes right through that area but again this was not nerve pain. And then there was the the socket, the ligament tissue that forms the ...

6. A Study Evaluating MM-310 in Patients With Solid Tumors - Mayo Clinic

   ... conduction abnormalities, or controlled and well treated chronic atrial fibrillation); Patients who are not appropriate candidates for participation in this ...

7. Aurora A Kinase Inhibitor MLN8237 and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma - Mayo Clinic

   Severe uncontrolled ventricular arrhythmias or electrocardiographic evidence of active conduction system abnormalities; Cardiac amyloidosis with hypotension ...

8. A Study Using Docetaxel with or without MLN1117 in Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer - Mayo Clinic

   ... conduction system abnormalities; Fridericia's corrected QT interval > 475 milliseconds (msec) (males) or > 450 msec (females) on a 12-lead ECG during the ...

9. A Study of Taxane, Trastuzumab, and Pertuzumab With or Without Atezolizumab in Treating Metastatic Breast Cancer Patients - Mayo Clinic

   Conduction abnormality requiring a pacemaker;; Valvular disease with documented compromise in cardiac function; or; Symptomatic pericarditis. History of ...

10. 221AD302 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease - Mayo Clinic

    History of unstable angina, myocardial infarction, advanced chronic heart failure, or clinically significant conduction abnormalities within 1 year prior to ...